Found: 86
Select item for more details and to access through your institution.
A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [<sup>18</sup>F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1042, doi. 10.1007/s10637-022-01286-8
- By:
- Publication type:
- Article
A phase 1 study to assess the safety, pharmacokinetics, and anti-tumor activity of the androgen receptor n-terminal domain inhibitor epi-506 in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 322, doi. 10.1007/s10637-021-01202-6
- By:
- Publication type:
- Article
Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 300, doi. 10.1007/s10637-021-01180-9
- By:
- Publication type:
- Article
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 315, doi. 10.1007/s10637-018-0663-0
- By:
- Publication type:
- Article
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1158, doi. 10.1007/s10637-018-0679-5
- By:
- Publication type:
- Article
First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 3, p. 315, doi. 10.1007/s10637-016-0419-7
- By:
- Publication type:
- Article
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 112, doi. 10.1007/s10637-015-0307-6
- By:
- Publication type:
- Article
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1395, doi. 10.1007/s10637-010-9484-5
- By:
- Publication type:
- Article
A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 6, p. 583, doi. 10.1007/s10637-005-1028-z
- By:
- Publication type:
- Article
Phase II trial of fenretinide in advanced renal carcinoma.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 179, doi. 10.1007/s10637-005-5864-7
- By:
- Publication type:
- Article
Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2022, v. 8, n. 3, p. 1, doi. 10.1101/mcs.a006203
- By:
- Publication type:
- Article
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
- Published in:
- BJU International, 2017, v. 120, n. 6, p. 782, doi. 10.1111/bju.13705
- By:
- Publication type:
- Article
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy.
- Published in:
- Nutrients, 2024, v. 16, n. 11, p. 1630, doi. 10.3390/nu16111630
- By:
- Publication type:
- Article
Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms.
- Published in:
- International Journal of Surgical Pathology, 2023, v. 31, n. 6, p. 1027, doi. 10.1177/10668969221125793
- By:
- Publication type:
- Article
Adjuvant Everolimus in Non–Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2425288, doi. 10.1001/jamanetworkopen.2024.25288
- By:
- Publication type:
- Article
Adjuvant Chemo-/Hormonal Therapy Trials for Locally Advanced Prostate Cancer.
- Published in:
- Current Oncology Reports, 2000, v. 2, n. 5, p. 402, doi. 10.1007/s11912-000-0059-z
- By:
- Publication type:
- Article
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer.
- Published in:
- AUANews, 2023, v. 28, n. 1, p. 32
- By:
- Publication type:
- Article
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-021-02236-7
- By:
- Publication type:
- Article
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study.
- Published in:
- Oncology, 2023, v. 101, n. 6, p. 375, doi. 10.1159/000530719
- By:
- Publication type:
- Article
Surgical excision of duodenal/pancreatic metastatic renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00218
- By:
- Publication type:
- Article
Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients.
- Published in:
- Prostate Cancer (20903111), 2015, v. 2015, p. 1, doi. 10.1155/2015/285193
- By:
- Publication type:
- Article
Current State of Systemic Therapies for Advanced Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 3, p. 1, doi. 10.1007/s11912-020-0892-1
- By:
- Publication type:
- Article
Cabozantinib as a Novel Therapy for Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 76, doi. 10.1007/s11912-012-0289-x
- By:
- Publication type:
- Article
Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy.
- Published in:
- British Journal of Haematology, 2001, v. 115, n. 1, p. 66, doi. 10.1046/j.1365-2141.2001.03056.x
- By:
- Publication type:
- Article
Percutaneous cryoablation of adrenal metastases: technical feasibility and safety.
- Published in:
- Abdominal Radiology, 2021, v. 46, n. 6, p. 2805, doi. 10.1007/s00261-020-02848-1
- By:
- Publication type:
- Article
Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma.
- Published in:
- Oncologist, 2023, v. 28, p. S15, doi. 10.1093/oncolo/oyad216.026
- By:
- Publication type:
- Article
Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies.
- Published in:
- Oncologist, 2023, v. 28, p. S14, doi. 10.1093/oncolo/oyad216.024
- By:
- Publication type:
- Article
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1026, doi. 10.1002/onco.13925
- By:
- Publication type:
- Article
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1104, doi. 10.1002/onco.13758
- By:
- Publication type:
- Article
Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 422, doi. 10.1634/theoncologist.2019-0605
- By:
- Publication type:
- Article
The Impact of Cisplatin‐ or Non‐Cisplatin‐Containing Chemotherapy on Long‐Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1348, doi. 10.1634/theoncologist.2018-0739
- By:
- Publication type:
- Article
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1151, doi. 10.1634/theoncologist.2018-0749
- By:
- Publication type:
- Article
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1149, doi. 10.1634/theoncologist.2019-0331
- By:
- Publication type:
- Article
Academic Cancer Center Phase I Program Development.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 369, doi. 10.1634/theoncologist.2016-0409
- By:
- Publication type:
- Article
Characterizing the outcomes of metastatic papillary renal cell carcinoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 5, p. 902, doi. 10.1002/cam4.1048
- By:
- Publication type:
- Article
Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 186, doi. 10.1002/cam4.986
- By:
- Publication type:
- Article
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 21, p. 3957, doi. 10.1002/cncr.33679
- By:
- Publication type:
- Article
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 3, p. 354, doi. 10.1002/cncr.33238
- By:
- Publication type:
- Article
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y
- By:
- Publication type:
- Article
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y
- By:
- Publication type:
- Article
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.
- Published in:
- ISRN Oncology, 2012, p. 1, doi. 10.5402/2012/242850
- By:
- Publication type:
- Article
Perioperative Approaches to Kidney Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 1, p. 56
- By:
- Publication type:
- Article